Aignostics secures USD 34 million B-series financing
The spin-off of Charité - Universitätsmedizin Berlin and the Berlin Institute of Health at Charité (BIH) was funded by the BIH DHA program in 2018.
The spin-off of Charité - Universitätsmedizin Berlin and the Berlin Institute of Health at Charité (BIH) was funded by the BIH DHA program in 2018.
Medical research at Charité - Universitätmedizin Berlin and the Berlin Institute of Health (BIH) should have the greatest possible impact on society and the economy, according to the mission of Charité BIH Innovation (CBI), the joint technology transfer of Charité and BIH. In order to provide a platform for the exchange of experiences and ideas…
COReS team members recently attended the 5th International SR-SAVI Conference in Zurich, where they explored advances in transparency, rigor, and AI integration in systematic reviews—and celebrated Community Manager Friederike Kohrs’ award-winning poster on the COReS project
The European Rare Diseases Research Alliance (ERDERA) is holding today, October 28, its official launch event, where it will set out its vision and ambition for tackling rare diseases as part of the EU’s research strategy in this field. Representatives of the European Commission, patients’ organizations and ERDERA project groups will present their…
This year, four projects supervised by Charité BIH Innovation qualified for the Go-Bio initial program of the Federal Ministry of Education and Research (BMBF), including NEUROLITH, SIC, KardioDetekt and Mykopoint. The program is an initiative of the Federal Ministry of Education and Research (BMBF) and promotes the identification and development…
UNFPA, the United Nations Population Fund, will launch its new “WomenX Collective” programme at the World Health Summit in Berlin on October 14, followed the next day by the opening of its first hub office in a planned global network of centres specializing in the promotion of women's health, especially sexual and reproductive health, in the German…
Regulatory T cells (Treg) are a type of immune cell that can suppress harmful inflammation caused by autoimmune diseases or after organ transplants. As a living drug, they are promising for precision medicine, but until now it has been necessary to produce a specific cell product for each patient. The BIH research group led by Prof. Dr. Julia…
On November 7 and 8, the final ORCHESTRA conference took place in Verona, Italy. The project, funded by the European Commission, ran for four years and was launched during the COVID-19 pandemic to generate new knowledge about SARS-CoV-2 infection. It involves a network of 37 partners from Europe and beyond.